Development of a predictive model for patients with bone metastases referred to palliative radiotherapy: Secondary analysis of a multicenter study (the <scp>PRAIS</scp> trial)
We successfully developed three PMs for OS based on easily accessible clinical and laboratory parameters for patients referred to palliative RT for painful BMs. While our findings are promising, it is important to recognize that this was an exploratory trial. The implementation of these tools into clinical practice warrants further investigation and confirmation through subsequent studies with separate databases.
Authors
- Savino Cilla (ORCID: https://orcid.org/0000-0001-6711-350X)
- Pål Klepstad (ORCID: https://orcid.org/0000-0003-2804-8447)
- Augusto Caraceni (ORCID: https://orcid.org/0000-0002-0375-6204)
- Monia Dall’Agata (ORCID: https://orcid.org/0000-0002-2270-5269)
- Federica Medici (ORCID: https://orcid.org/0000-0001-7867-8987)
- Ragnhild Habberstad (ORCID: https://orcid.org/0000-0002-7788-1884)
- A.G. Morganti (ORCID: https://orcid.org/0000-0001-9793-3410)
- Marco Maltoni (ORCID: https://orcid.org/0000-0002-4604-9825)
- R Rossi (ORCID: https://orcid.org/0009-0002-7076-9846)
- Stein Kaasa (ORCID: https://orcid.org/0000-0002-3268-8036)
Institutions
- Oslo University Hospital (NO)
- University of Milan (IT)
- Norwegian University of Science and Technology (NO)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- St Olav's University Hospital (NO)
- Azienda USL di Bologna (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1002/cam4.70050
- Citations
- 5
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 2.86